Joint Injection

Joint Injection (General Practitioner) Consent Patient [Mrs. Eleanor Vance], aged [68], provided informed consent for a left knee intra-articular steroid injection. She was thoroughly informed about the potential benefits, including pain reduction and decreased inflammation, and risks, such as infection, bleeding, allergic reaction, and temporary increase in pain. All her questions were answered, and she verbally confirmed understanding. Written consent was obtained and signed prior to the procedure. Procedure "Injected using aseptic, non-touch technique. The medication used was depo-medrone with Lidocaine." The injection was administered into the left knee joint using an anterior approach, aiming for the suprapatellar pouch. The skin was prepped with chlorhexidine, and a 23-gauge needle was used to access the joint space. No immediate complications were observed. Depo-Medrone batch number: [P54321], expiry date: [01/03/2026]. Lidocaine batch number: [L98765], expiry date: [01/10/2025].